Recent research demonstrated that LDHB silencing decreased the development and spread of xenograft tumors (47), TKT, a crucial enzyme operating between the oxidative arm and the nonoxidative arm of PPP, is highly expressed in the tissues of NSCLC patients (48). Here, TKT is linked to non-small cell lung carcinoma.